Mumbai: Covid-19 is positive in its recent state, and nearly 50% of the samples sent for genomic sequencing have a newly identified infectious SARS-CoV-2 called B.1.617. There are high Indian variants.
Most of these samples are from Vidarbha, and the samples submitted by the city have not previously shown the B.1.617 variant, INSACOG, a group of 10 national laboratories performing whole-genome sequences of samples. The scientists involved in say. So far, the United Ministry of Health has not provided specific details on the whole genome sequencing project. As of Thursday, 13,614 whole-genome sequence samples were processed in 10 INSACOG labs, according to Friday’s correspondence.
Two mutations known to be capable of escaping antibodies
Of these, 1,189 samples have been tested positive for SARSCOV-2-concerned variants in India. These include 1,109 samples containing British variants. 79 samples containing the South African variant and one sample containing the Brazilian variant, “said the ministry’s release.
Some information about the results of the samples sent by the state was given to state health minister Rajesh Tope at a virtual meeting with federal health minister Dr. Harsh Vardhan on Saturday. Of the 1,100 samples sent so far, 500 were surveyed, Tope said. “We asked the central government for a detailed report, but it was said that it would only be available at the end of the study,” he said.
The main concern in the state and other countries is the high infectivity of the subspecies, as the Indian subspecies have already been isolated in multiple samples from the United Kingdom and the United States. “The new variants are said to be highly infectious, so we asked the center to report and revised the guidelines, if any,” said Tope.
“There are changes in some samples, but there is no comment on whether to explain this surge in Maharashtra,” said Dr. Archana Patil, director of health services.
B.1.617 was first identified by scientists at the Institute for Genome Integrated Biology in Delhi. They noted two mutations known to be capable of evading antibodies, L452R and E484K.
Articles written by experts around the world state that Indian variants may be driving the current wave that “at least partially” dominates the country. Dr. Anuraguagrawar, director of IGIB, said that about 15,000 Covid-19-positive samples have been studied since December. “It’s present in a small portion of the sample, but its presence has increased in recent weeks,” said Dr. Agrawar.